Hexagon Capital Partners LLC Aileron Therapeutics Inc Transaction History

Hexagon Capital Partners LLC

  • $508 Million
  • Q3 2024

A detailed history of Hexagon Capital Partners LLC transactions in Aileron Therapeutics Inc stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 213 shares of ALRN stock, worth $474. This represents 0.0% of its overall portfolio holdings.

Number of Shares
213
Previous 213 -0.0%
Holding current value
$474
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024
BUY
$2.77 - $6.2 $590 - $1,320
213 New
213 $0

Others Institutions Holding ALRN

# of Institutions
1
Shares Held
213
Call Options Held
0
Put Options Held
0
View Full List

About AILERON THERAPEUTICS INC

ALRN Quotes by TradingView
  • Ticker ALRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,823,600
  • Market Cap $203M
  • Description
  • Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advan...
More about ALRN
Track This Portfolio

Track Hexagon Capital Partners LLC Portfolio

Follow Hexagon Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email